Bay Street News, 2018

Planning Phase II Trial VANCOUVER, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) — Nash Pharmaceuticals Inc., a wholly owned subsidiary […]

TORONTO, Nov. 13, 2018 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (the “Company” or “Bunker”) (CSE:BNKR) is pleased it has […]

TORONTO, Nov. 13, 2018 (GLOBE NEWSWIRE) — Graph Blockchain Inc. (“Graph” or “Company”) (CSE: GBLC) is very pleased to announce […]

DENVER, Nov. 13, 2018 (GLOBE NEWSWIRE) — Bonanza Creek Energy, Inc. (NYSE: BCEI) (“Bonanza Creek” or the “Company”) today announces the hiring […]

NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) — Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on […]

Conference Call Today at 9:00 a.m. Eastern Time NEWTOWN, Pa., Nov. 13, 2018 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (Nasdaq: […]

CALGARY, Alberta and SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing […]

DALLAS, Nov. 13, 2018 (GLOBE NEWSWIRE) — TBK Bank, SSB, a wholly owned subsidiary of Triumph Bancorp, Inc. (Nasdaq: TBK), […]

HOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced detailed results of […]

Key Highlights: Top-line results from the confirmatory Phase III study with TALICIA® for H. pylori infection are on track to […]